−0.55EUR
−15.76 MEUR
2.81 MEUR
12.43 M
About HYLORIS
Sector
CEO
Stijn van Rompay
Headquarters
Liege
Website
Founded
2017
ISIN
BE0974363955
FIGI
BBG00V7M6KN9
Hyloris Pharmaceuticals SA engages in the development and reformulating of pharmaceutical products. It offers commercial-stage products, Sotalol IV for the treatment of atrial fibrillation; and Maxigesic IV, a novel, dual modeof-action non-opioid analgesic for the treatment of post-operative pain. The company was founded by Stijn van Rompay and Thomas Jacobsen in 2012 and is headquartered in Liege, Belgium.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of HYL is 12.00 EUR — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange HYLORIS stocks are traded under the ticker HYL.
HYL stock is 2.52% volatile and has beta coefficient of −0.04. Check out the list of the most volatile stocks — is HYLORIS there?
One year price forecast for HYLORIS has a max estimate of 22.10 EUR and a min estimate of 21.00 EUR.
Yes, you can track HYLORIS financials in yearly and quarterly reports right on TradingView.
HYL stock has fallen by 2.44% compared to the previous week, the month change is a 2.56% rise, over the last year HYLORIS has showed a 13.04% decrease.
HYL net income for the last quarter is −9.13 M EUR, while the quarter before that showed −6.63 M EUR of net income which accounts for −37.59% change. Track more HYLORIS financial stats to get the full picture.
Today HYLORIS has the market capitalization of 336.01 M, it has increased by 5.51% over the last week.
No, HYL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, HYL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HYLORIS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HYLORIS technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HYLORIS stock shows the sell signal. See more of HYLORIS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on HYLORIS future price: according to them, HYL price has a max estimate of 22.10 EUR and a min estimate of 21.00 EUR. Read a more detailed HYLORIS forecast: see what analysts think of HYLORIS and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HYLORIS EBITDA is −17.54 M EUR, and current EBITDA margin is −615.92%. See more stats in HYLORIS financial statements.